A Collaborative Practice Agreement (CPA) is a legal document in the United States that establishes a legal relationship between clinical pharmacists and cooperating physicians, which allows pharmacists to participate in the collaborative management of drug therapy (CDTM). D`Arkansan CPs apply to individual pharmacists, practitioners who are “authorized to prescribe drugs” and who are indicated in patients. The specific disease stipulates that pharmacists administer, with indicated medications that the pharmacist can use are necessary. Pharmacists are required to document their interventions for discussion with the collaborative practitioner and must keep these records for at least 2 years after the date of registration. [26] In 2015, the American College of Clinical Pharmacy (ACCP) published an updated white paper on the management of collaborative drug therapy. CacP regularly publishes updates on this topic, with previous publications in 2003 and 1997. The document describes the recent history of CPAs, legislative advances and discussed payment models for collaborative drug therapy management activities. [1] In 2010, the American Medical Association (AMA) published a series of reports entitled “AMA Scope of Practice Data Series.” [61] One report focused on the pharmacy profession, which criticized the formation of CPAs as an attempt by pharmacists to intervene with the physician. In response to the report, a collaboration of seven national pharmacists` associations prepared a response to the WADA Pharmacists Report.

[62] The response called on WADA to correct its report and publish the revised report with Errata. [63] In 2011, WADA`s Chamber of Deputies adopted a more flexible tone of the APhA in response to contributions from aPhA and other pharmacy professional associations and finally adopted the following resolution, which paid attention to the refusal of independent conduct agreements (rather than collaborative or dependent agreements): the term “cooperation agreement” was also referred to as a consultation agreement , agreeing to the practice of collaborative pharmacy. , doctor-pharmacist agreement, permanent contract or permanent protocol and medical delegation. [6] A Collaborative Practice Agreement is a legal document in the United States that establishes a formal relationship between pharmacists (often clinical pharmacy specialists) and cooperating physicians, in order to create a legal and ethical basis for pharmacists involved in collaborative therapy management. [7] Although CPAs are not a prerequisite for the provision of collaborative care, they can be used to improve the efficiency and effectiveness of collaborative care delivery. If they are used to their full potential, CPAs have the opportunity to improve access to medical care, expand services available to patients, improve efficiency and coordination of care, and use the expertise of pharmacists in drug matters to complement the skills and knowledge of other members of the health team.